Featured:
COVID-19 infection more likely than vaccines to cause rare cardiovascular complications
16 December 2021
COVID-19 Cardiovascular & metabolic QResearch
Led by the University of Oxford, a team of UK-based researchers have today reported results of the largest ever study to compare the risks of cardiovascular events, such as myocarditis, pericarditis, and cardiac arrhythmia, between different vaccines and COVID-19 infection, and the first to investigate the association between cardiac events and the Oxford-AstraZeneca vaccine.
Recruitment begins for national community COVID-19 antiviral trial
8 December 2021
COVID-19 Clinical trials Public engagement & involvement
Researchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications – partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.
Three out of four people with heart failure could be diagnosed sooner, potentially improving quality of life and reducing costs to the healthcare system.
29 November 2021
Health Services Research Policy & health systems
Researchers from the University of Oxford have today reported that only 1 in 4 people diagnosed with heart failure received a simple, recommended blood test that could have resulted in an earlier diagnosis at a more treatable stage.
Designing and implementing an educational framework for paramedics rotating into primary care
18 November 2021
Health Services Research Policy & health systems
Georgette Eaton shares an overview of her research as part of her NIHR Doctoral Research Fellowship focusing on the employment of paramedics in primary care.
Department Researchers work highlighted at NCRI festival: Fewer cases of children’s cancer picked up during COVID pandemic
12 November 2021
Big data COVID-19 Cancer QResearch
A study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic. The research, presented at the NCRI Festival, also shows that children who were diagnosed with cancer during the first wave of the pandemic were more likely to have been admitted to intensive care prior to their diagnosis.
Department Researchers work highlighted at NCRI festival: New symptoms identified that could help doctors diagnose pancreatic cancer
8 November 2021
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms – feeling thirsty and having dark urine – in a study presented today (Monday, 8th Jan) at the NCRI Festival.
PCR cycle threshold may be key to predicting infectiousness of people with asymptomatic and pre-symptomatic COVID-19, suggests new review.
1 November 2021
An international team of researchers, led from Centre for Evidence-based Medicine based in the Nuffield Department of Primary Care Health Sciences, University of Oxford, and funded by the World Health Organization and the National Institute for Health Research School for Primary Care Research, have today announced the findings from the most complete analysis of high-quality covid transmission studies in asymptomatic and pre-symptomatic people to date.
Department awarded funding to complete community COVID-19 antiviral trial
26 October 2021
Awards & appointments COVID-19
Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.
COVID-19 infection has greater risk of causing very rare neurological events than vaccines
25 October 2021
COVID-19 Digital health & innovation QResearch
Researchers from across the UK, led by the University of Oxford, have today reported on the risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.
Professor Trish Greenhalgh elected as new member of the National Academy of Medicine (NAM)
21 October 2021
On Monday, the National Academy of Medicine (NAM) announced the election of 90 regular members and 10 international members during its annual meeting, including our department's very own Trish Greenhalgh. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
Pancreatic cancer early detection funds awarded to department researchers
19 October 2021
Dr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.
Department led Covid research partnership wins national computing innovation award
11 October 2021
Awards & appointments COVID-19 QResearch
A collaboration which used anonymised GP records to identify 1.5m people most at risk from Covid-19 and prioritise them for vaccination has won the prestigious John Perry Prize for computing innovation in primary care.
Reduction in UK red and processed meat intake, but more needed to meet our climate targets
8 October 2021
Cardiovascular & metabolic Policy & health systems
Daily meat consumption in the UK has decreased by approximately 17.4g per person per day – just under a 17% reduction – in the last decade finds new research from the University of Oxford. Between 2008/09 and 2018/19 people in the UK reduced both the amount of red and processed meat they eat, while slightly increasing their white meat consumption. Yet, this reduction is significantly less than the 30% reduction the National Food Strategy has recently called for within the next ten years.
Congratulations to Professor Trish Greenhalgh on receiving Highly Commended O2RB Excellence in Impact Award 2021!
6 October 2021
Professor of Primary Care Health Sciences, Trish Greenhalgh, is one of six outstanding Oxford researchers, highly commended for significant contribution to policy discussions and public understanding of COVID-19 precautions internationally, in the O2RB Excellence in Impact Awards 2021.
Hormone therapy not linked to increased risk of developing dementia
30 September 2021
Policy & health systems QResearch
Use of menopausal hormone therapy (MHT), also known as hormone replacement therapy, HRT) is not associated with an increased risk of developing dementia, regardless of hormone type, dose, or duration, conclude a team of researchers from across the UK.
Smoking associated with higher risk of death and hospitalisation with COVID-19
28 September 2021
Smoking is highly likely to worsen the severity of COVID-19 and the risk of dying with the infection, finds a large study led by researchers from the University of Oxford and published online in the respiratory journal Thorax.
Congratulations to our newest Associate Professors!
23 September 2021
We are delighted to announce that Jamie Hartmann-Boyce, James Sheppard and Sarah Tonkin-Crine have been awarded the title of Associate Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the department and the wider Medical Sciences Division.
QCovid highly commended for ‘best use of technology in Patient Safety’ at the 2021 HSJ Patient Safety Awards
23 September 2021
Professor Julia Hippisley-Cox and her team have been Highly Commended in the ‘Best use of technology in Patient Safety’ category for the QCovid risk calculator at this year’s Health Service Journal Patient Safety Awards.
Can electronic cigarettes help people quit smoking? (Updated)
16 September 2021
Published this week is the fourth update of the Cochrane review of ‘Electronic cigarettes for smoking cessation’, and the second since it switched to a living review format in October 2020. This review brings together the most up to date research findings on the effect and safety of using electronic cigarettes to help people to stop smoking.
MSc EBHC students awarded EBHC Dissertation Prize for outstanding Dissertation
16 September 2021
Awards & appointments Research methods & EBM Students
Congratulations to Michael Tringale, who recently completed the MSc in Evidence-Based Health Care, and Claire Duddy, who recently completed the MSc in EBHC Systematic Reviews, as they are both awarded this year's EBHC Dissertation Prize for outstanding dissertation.
Blog: Opinions from our research and teaching
Contact our communications team
Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.